Sponsored by
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Risk & Compliance
Do You Spend Enough Time Assessing Strategic Risks?
Devote more time to strategic risk management and you won’t be caught completely unprepared.
By
Perry D. Wiggins, C.P.A.
| January 26, 2022
Read More
Resources
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Sign Up
Sponsored by
Takeover
Mergers & Acquisitions
A Dedicated M&A Team May Be Worth It
A new academic study finds that specialized M&A staffs help acquirers identify targets that have higher synergies.
By
Vincent Ryan
| May 11, 2021
Read More
M&A
P&G Scraps Deal to Buy Billie Razor Startup
The termination of the proposed merger comes after regulators alleged it would cause "significant harm" to consumers.
By
Matthew Heller
| January 5, 2021
Read More
M&A
Cinema Chain Merger Heads for Court Fight
Cineplex accuses Cineworld of "buyer's remorse" and seeking to avoid its obligations under the merger agreement because of the COVID-19 pandemic.
By
Matthew Heller
| June 15, 2020
Read More
Credit & Capital
Akorn Files for Chapter 11 After Failed Takeover
The generic drugmaker listed $10 billion of debt and $10 billion of assets.
By
Lauren Muskett
| May 21, 2020
Read More
M&A
Perry Ellis Ends Takeover Talks With Randa
The apparent demise of Randa's $460 million proposal clears the way for Perry Ellis to be taken private by founder George Feldenkreis.
By
Matthew Heller
| August 14, 2018
Read More
Strategy
Smurfit Spurns International Paper’s New Offer
The Irish packaging firm says the revised proposal "does not make strategic sense" and would expose shareholders to "significantly greater leverage."
By
Matthew Heller
| March 26, 2018
Read More
Strategy
Fidelity National Buys Title Insurance Rival
The $1.2 billion purchase of Stewart Information Services will strengthen Fidelity's position as the No. 1 title insurance underwriter in the U.S.
By
Matthew Heller
| March 19, 2018
Read More
Technology
Qualcomm Agrees to Talk With Broadcom
The companies will meet on Wednesday even though Qualcomm has rejected its rival's improved $121 billion takeover offer as inadequate.
By
Matthew Heller
| February 12, 2018
Read More
Risk & Compliance
CPA Accused of Illegal Trades on Drug Firm News
The former accountant at Celator Pharmaceuticals allegedly passed on tips about market-moving announcements by the company to friends.
By
Matthew Heller
| September 1, 2017
Read More
Strategy
Bass Pro Shops Reels in Cabela’s for $5.5B
The merger between two of the largest outdoor gear retailers would add Cabela's 85 stores and "loyal following" to Bass Pro's system.
By
Matthew Heller
| October 3, 2016
Read More
Mergers & Acquisitions
Pier 1 Counters Hedge Fund With Poison Pill
The retailer follows Alden Global's purchase of a 9.5% stake with a plan to protect shareholders from “coercive or unfair” tactics.
By
Matthew Heller
| September 28, 2016
Read More
Strategy
Bayer Clinches Monsanto Takeover for $66B
The deal continues the wave of consolidation in agribusiness, pairing Bayer's strength in crop chemicals with Monsanto's portfolio of seed products.
By
Matthew Heller
| September 14, 2016
Read More
Strategy
Pfizer Makes Cancer Play With Medivation Deal
The $14 billion acquisition would add the best-selling prostate cancer drug Xtandi to Pfizer's growing oncology portfolio.
By
Matthew Heller
| August 22, 2016
Read More
Strategy
Mondelez Offer Not Sweet Enough for Hershey
The $22.8 billion proposal would create the world's largest candy maker but the Hershey Trust may stand in the way of any suitor.
By
Matthew Heller
| June 30, 2016
Read More
M&A
Williams Cos. Fights for Energy Transfer Merger
Investors backed Williams' board, which is appealing a judge's ruling that Energy Transfer can walk away from the deal.
By
Matthew Heller
| June 28, 2016
Read More
Next
